183 related articles for article (PubMed ID: 37250303)
1. Deubiquitinase USP1 influences the dedifferentiation of mouse pancreatic β-cells.
Francis M; Bhaskar S; Komanduri S; Sheshadri P; Prasanna J; Kumar A
iScience; 2023 May; 26(5):106771. PubMed ID: 37250303
[TBL] [Abstract][Full Text] [Related]
2. Dynamics of Ubiquitination in Differentiation and Dedifferentiation of Pancreatic β-cells: Putative Target for Diabetes.
Francis M; Bhaskar S; Vishnuvajhala S; Prasanna J; Kumar A
Curr Protein Pept Sci; 2022; 23(9):602-618. PubMed ID: 35466872
[TBL] [Abstract][Full Text] [Related]
3. CRISPR/Cas9-based genome-wide screening for deubiquitinase subfamily identifies USP1 regulating MAST1-driven cisplatin-resistance in cancer cells.
Tyagi A; Kaushal K; Chandrasekaran AP; Sarodaya N; Das S; Park CH; Hong SH; Kim KS; Ramakrishna S
Theranostics; 2022; 12(13):5949-5970. PubMed ID: 35966591
[No Abstract] [Full Text] [Related]
4. Loss of Deubiquitinase USP1 Blocks Pancreatic β-Cell Apoptosis by Inhibiting DNA Damage Response.
Gorrepati KDD; Lupse B; Annamalai K; Yuan T; Maedler K; Ardestani A
iScience; 2018 Mar; 1():72-86. PubMed ID: 30227958
[TBL] [Abstract][Full Text] [Related]
5. USP1 deubiquitinase: cellular functions, regulatory mechanisms and emerging potential as target in cancer therapy.
García-Santisteban I; Peters GJ; Giovannetti E; Rodríguez JA
Mol Cancer; 2013 Aug; 12():91. PubMed ID: 23937906
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of USP1 enhances anticancer drugs-induced cancer cell death through downregulation of survivin and miR-216a-5p-mediated upregulation of DR5.
Woo SM; Kim S; Seo SU; Kim S; Park JW; Kim G; Choi YR; Hur K; Kwon TK
Cell Death Dis; 2022 Sep; 13(9):821. PubMed ID: 36153316
[TBL] [Abstract][Full Text] [Related]
7. ML323 suppresses the progression of ovarian cancer
Song B; Jiang Y; Jiang Y; Lin Y; Liu J
Front Genet; 2022; 13():917481. PubMed ID: 35923700
[No Abstract] [Full Text] [Related]
8. USP1 inhibition suppresses the progression of osteosarcoma via destabilizing TAZ.
Yuan P; Feng Z; Huang H; Wang G; Chen Z; Xu G; Xie Z; Jie Z; Zhao X; Ma Q; Wang S; Shen Y; Huang Y; Han Y; Ye H; Wang J; Shi P; Sun X
Int J Biol Sci; 2022; 18(8):3122-3136. PubMed ID: 35637948
[TBL] [Abstract][Full Text] [Related]
9. Mutations in the 'Fingers' subdomain of the deubiquitinase USP1 modulate its function and activity.
Olazabal-Herrero A; García-Santisteban I; Rodríguez JA
FEBS J; 2016 Mar; 283(5):929-46. PubMed ID: 26758085
[TBL] [Abstract][Full Text] [Related]
10. The Role of the Complex USP1/WDR48 in Differentiation and Proliferation Processes in Cancer Stem Cells.
Goncalves JM; Cordeiro MMR; Rivero ERC
Curr Stem Cell Res Ther; 2017; 12(5):416-422. PubMed ID: 28302046
[TBL] [Abstract][Full Text] [Related]
11. The promotive role of USP1 inhibition in coordinating osteogenic differentiation and fracture healing during nonunion.
Huang J; Zhou H; He L; Zhong L; Zhou D; Yin Z
J Orthop Surg Res; 2023 Mar; 18(1):152. PubMed ID: 36859264
[TBL] [Abstract][Full Text] [Related]
12. USP1-UAF1 deubiquitinase complex stabilizes TBK1 and enhances antiviral responses.
Yu Z; Song H; Jia M; Zhang J; Wang W; Li Q; Zhang L; Zhao W
J Exp Med; 2017 Dec; 214(12):3553-3563. PubMed ID: 29138248
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Ubiquitin Specific Protease 1 Sensitizes Colorectal Cancer Cells to DNA-Damaging Chemotherapeutics.
Xu X; Li S; Cui X; Han K; Wang J; Hou X; Cui L; He S; Xiao J; Yang Y
Front Oncol; 2019; 9():1406. PubMed ID: 31921663
[TBL] [Abstract][Full Text] [Related]
14. The WD40-repeat protein-containing deubiquitinase complex: catalysis, regulation, and potential for therapeutic intervention.
Villamil MA; Liang Q; Zhuang Z
Cell Biochem Biophys; 2013 Sep; 67(1):111-26. PubMed ID: 23797609
[TBL] [Abstract][Full Text] [Related]
15. Blockade of Deubiquitylating Enzyme USP1 Inhibits DNA Repair and Triggers Apoptosis in Multiple Myeloma Cells.
Das DS; Das A; Ray A; Song Y; Samur MK; Munshi NC; Chauhan D; Anderson KC
Clin Cancer Res; 2017 Aug; 23(15):4280-4289. PubMed ID: 28270494
[No Abstract] [Full Text] [Related]
16. A selective USP1-UAF1 inhibitor links deubiquitination to DNA damage responses.
Liang Q; Dexheimer TS; Zhang P; Rosenthal AS; Villamil MA; You C; Zhang Q; Chen J; Ott CA; Sun H; Luci DK; Yuan B; Simeonov A; Jadhav A; Xiao H; Wang Y; Maloney DJ; Zhuang Z
Nat Chem Biol; 2014 Apr; 10(4):298-304. PubMed ID: 24531842
[TBL] [Abstract][Full Text] [Related]
17. Identification of deubiquitinase targets of isothiocyanates using SILAC-assisted quantitative mass spectrometry.
Lawson AP; Bak DW; Shannon DA; Long MJC; Vijaykumar T; Yu R; Oualid FE; Weerapana E; Hedstrom L
Oncotarget; 2017 Aug; 8(31):51296-51316. PubMed ID: 28881649
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and structure-activity relationship studies of N-benzyl-2-phenylpyrimidin-4-amine derivatives as potent USP1/UAF1 deubiquitinase inhibitors with anticancer activity against nonsmall cell lung cancer.
Dexheimer TS; Rosenthal AS; Luci DK; Liang Q; Villamil MA; Chen J; Sun H; Kerns EH; Simeonov A; Jadhav A; Zhuang Z; Maloney DJ
J Med Chem; 2014 Oct; 57(19):8099-110. PubMed ID: 25229643
[TBL] [Abstract][Full Text] [Related]
19. Glucagon receptor blockage inhibits β-cell dedifferentiation through FoxO1.
Wang K; Cui X; Li F; Xia L; Wei T; Liu J; Fu W; Yang J; Hong T; Wei R
Am J Physiol Endocrinol Metab; 2023 Jan; 324(1):E97-E113. PubMed ID: 36383639
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
